Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07777328 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Effect of 5-hydroxytryptophan on ADHD Traits and Eye Movements

StatusRecruiting
PhaseNot applicable
Started2025-11-25
View on ClinicalTrials.gov ↗
The aim of this project is to look at the impact of 5-Hydroxytryptophan (5-HTP) on distractibility. 5-HTP is the precursor to the neurotransmitter serotonin and is a chemical that the body produces naturally. There is evidence that distractibility is associated with a decreased level of serotonin. This research aims to see if giving people 5-HTP will alter their distractibility, which will form part of an initial assessment as to whether 5-HTP could be used to support people with attention problems. The study involves completing a short survey about mental health and behaviours, and if eligible, participation in an in-person study at the University of Sheffield. The in-person session involves completing some cognitive tasks to look at eye movement, taking 5-HTP or a sugar tablet with no active ingredients, and then completing the tasks again after a 90-minute wait.
Trial Details
NCT Number NCT07777328
Lead Sponsor University of Sheffield
Conditions Attention Deficit and Hyperactivity Disorder (ADHD), Attention Deficit Hyperactivity Disorder in Adults, Attention Deficits
Enrollment 150 participants
Start Date 2025-11-25
Primary Completion 2027-02 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2026-08-20